Publication & Citation Trends
Publications
0 total
Learning from late-stage trial failures in higher-risk myelodysplastic syndromes: towards adaptive and biomarker-enriched designs.
Cited by 0
Semantic Scholar
Body movement as a digital biomarker in chronic pain rehabilitation: a real-world pilot study using virtual reality
Cited by 1
Semantic Scholar
GC12 – Adjuvant docetaxel versus surveillance in intermediate or high-risk prostate cancer after radical curative radiotherapy: The final 10-year survival results of the SPCG-13 trial
Cited by 0
Semantic Scholar
Adjuvant Docetaxel Versus Surveillance in Intermediate- or High-risk Prostate Cancer After Radical Curative Radiotherapy: Final Survival Results from the SPCG-13 Trial. OA
Cited by 1
Semantic Scholar
Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD data
Cited by 2
Semantic Scholar
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer OA
Cited by 1
Semantic Scholar
Ex Vivo Venetoclax Sensitivity Predicts Clinical Response in Acute Myeloid Leukemia in the Prospective VenEx Trial.
Cited by 22
Semantic Scholar
Gestational Diabetes Mellitus and Labor Analgesia: Nationwide Register‐Based Analysis in Finland
Cited by 0
Semantic Scholar
Research Topics
Prostate Cancer Treatment and Research
(7)
HER2/EGFR in Cancer Research
(6)
Prostate Cancer Diagnosis and Treatment
(5)
Breast Cancer Treatment Studies
(5)
Advanced Radiotherapy Techniques
(3)
Affiliations
Turku University of Applied Sciences
Faron Pharmaceutical (Finland)
Mundipharma (South Korea)
National Public Health Laboratory
Pharmatest (Finland)